Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2014 1
2015 1
2016 1
2021 1
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Female orgasmic dysfunction and severe climacteric symptomatology in women aged 40 to 59 years: an independent association from an analysis of a multicenter Latin American study.
Urrunaga-Pastor D, Mezones-Holguin E, Blümel JE, Apolaya-Segura M, Barón G, Belzares E, Bencosme A, Calle A, Espinoza MT, Flores D, Izaguirre H, León-León P, Lima S, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Soto E, Vallejo MS, Tserotas K, Chedraui P. Urrunaga-Pastor D, et al. Menopause. 2022 Jun 1;29(6):654-663. doi: 10.1097/GME.0000000000001973. Menopause. 2022. PMID: 35674646
Association of muscle disorders in late postmenopausal women according to the type of experienced menopause.
Vallejo MS, Blümel JE, Chedraui P, Tserotas K, Salinas C, Rodrigues MA, Rodríguez DA, Rey C, Ojeda E, Ñañez M, Monterrosa-Castro Á, Gómez-Tabares G, Espinoza MT, Escalante C, Elizalde A, Dextre M, Calle A, Aedo S. Vallejo MS, et al. Menopause. 2024 Apr 30. doi: 10.1097/GME.0000000000002367. Online ahead of print. Menopause. 2024. PMID: 38688462
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J; IBIS-II investigators. Forbes JF, et al. Lancet. 2016 Feb 27;387(10021):866-73. doi: 10.1016/S0140-6736(15)01129-0. Epub 2015 Dec 11. Lancet. 2016. PMID: 26686313 Free PMC article. Clinical Trial.